EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the destructive synergy between IL-33 and Suilysin hemolysis on blood-brain barrier stability

Yang Fu iD, Jing Jie, Liang Lei, Mengmeng Liu, Junjie Wang, Liancheng Lei iD, Hongtao Liu iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.00612-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Yang Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Interleukin-33, Hemolysin Proteins, Hemolysis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Key Research Development Program of China, National Natural Science Foundation of China, Heilongjiang Provincial Health Commission Scientific Research Topic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Streptococcus suis type 2 (SS2) is a zoonotic pathogen capable of eliciting meningitis, presenting significant challenges to both the swine industry and public health. Suilysin (Sly), one of SS2 most potent virulence determinants, releases a surfeit of inflammatory agents following red blood cell lysis. Notably, while current research on Sly role in SS2-induced meningitis predominantly centers on its interaction with the blood-brain barrier (BBB), the repercussions of Sly hemolytic products on BBB function have largely been sidestepped. In this vein, our study delves into the ramifications of Sly-induced hemolysis on BBB integrity. We discern that Sly hemolytic derivatives exacerbate the permeability of Sly-induced in vitro BBB models. Within these Sly hemolytic products, Interleukin-33 (IL-33) disrupts the expression and distribution of Claudin-5 in brain microvascular endothelial cells, facilitating the release of Interleukin-6 (IL-6) and Interleukin-8 (IL-8), thereby amplifying BBB permeability. Preliminary mechanistic insights suggest that IL-33-driven expression of IL-6 and IL-8 is orchestrated by the p38-mitogen-activated protein kinase signaling, whereas matrix metalloproteinase 9 mediates IL-33-induced suppression of Claudin-5. To validate these in vitro findings, an SS2-infected mouse model was established, and upon intravenous administration of growth stimulation expressed gene 2 (ST2) antibodies, in vivo results further underscored the pivotal role of the IL-33/ST2 axis during SS2 cerebral invasion. In summation, this study pioneerly illuminates the involvement of Sly hemolytic products in SS2-mediated BBB compromise and spotlights the instrumental role and primary mechanism of IL-33 therein. These insights enrich our comprehension of SS2 meningitis pathogenesis, laying pivotal groundwork for therapeutic advancements against SS2-induced meningitis. IMPORTANCE The treatment of meningitis caused by Streptococcus suis type 2 (SS2) has always been a clinical challenge. Elucidating the molecular mechanisms by which SS2 breaches the blood-brain barrier (BBB) is crucial for the development of meningitis therapeutics. Suilysin (Sly) is one of the most important virulence factors of SS2, which can quickly lyse red blood cells and release large amounts of damage-associated molecular patterns, such as hemoglobin, IL-33, cyclophilin A, and so on. However, the impact of these hemolytic products on the function of BBB is unknown and ignored. This study is the first to investigate the effect of Sly hemolytic products on BBB function. The data are crucial for the study of the pathogenesis of SS2 meningitis and can provide an important reference for the development of meningitis therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierInterleukin-33Hemolysin ProteinsHemolysisStreptococcus suisEndothelial CellsAnimalsMiceHumansStreptococcal InfectionsInterleukin-6Interleukin-8SwineMatrix Metalloproteinase 9

Stichwörter der Autor:innen

IL-33Streptococcus suis type 2Suilysinblood-brain barrierhemolytic products

Substanzen

Interleukin-33Hemolysin ProteinssuilysinInterleukin-6Interleukin-8Matrix Metalloproteinase 9

Autor:innen und Institutionen

  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, College of Veterinary Medicine; Department of Respiratory Medic…
  • Key Laboratory of the Provincial Education, Department of Heilongjiang for Common Animal Disease Prevention and Treatment, College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
  • Department of Orthopaedics, Heilongjiang Provincial Hospital, Harbin, Heilongjiang, China.

ORCID-Profile: Yang Fu, Liancheng Lei, Hongtao Liu

Förderung

  • The National Key Research Development Program of China
  • National Natural Science Foundation of China
  • Heilongjiang Provincial Health Commission Scientific Research Topic

Zitieren

APA

Fu, Y., Jie, J., Lei, L., Liu, M., Wang, J., Lei, L., & Liu, H. (2024). Exploring the destructive synergy between IL-33 and Suilysin hemolysis on blood-brain barrier stability. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00612-24

Vancouver

Fu Y, Jie J, Lei L, Liu M, Wang J, Lei L, et al. Exploring the destructive synergy between IL-33 and Suilysin hemolysis on blood-brain barrier stability. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00612-24

BibTeX
@article{Fu2024,
  author = {Fu, Yang and Jie, Jing and Lei, Liang and Liu, Mengmeng and Wang, Junjie and Lei, Liancheng and Liu, Hongtao},
  title = {Exploring the destructive synergy between IL-33 and Suilysin hemolysis on blood-brain barrier stability},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.00612-24}
}
Kostenlos starten →